Moberg Pharma AB (publ)
SSE:MOB.ST
15.1 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||
Net Income
| -21.093 | -20.226 | -20.12 | -22.937 | 64.819 | 51.073 | 62.171 | 35.183 | 17.231 | -14.056 | 12.594 | -7.598 | -31.031 | -24.276 | -36.701 |
Depreciation & Amortization
| 2.099 | 2.582 | 2.584 | 2.513 | 36.926 | 38.369 | 15.734 | 11.216 | 8.069 | 6.105 | 0.713 | 0.464 | 0.145 | 0.132 | 0.082 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | -10.353 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0.912 | 0 | 0 |
Stock Based Compensation
| 2.308 | 1.458 | 0.631 | 1.034 | 3.35 | 2.326 | 1.748 | 1.333 | 0.112 | 0.808 | 0.851 | 1.447 | 0.985 | 0.861 | 0.755 |
Change In Working Capital
| -12.155 | -1.373 | 1.849 | -8.719 | 17.471 | 12.022 | -44.444 | -16.596 | -7.902 | 5.1 | -6.497 | -3.546 | -1.512 | -2.016 | -0.387 |
Accounts Receivables
| 0.424 | -0.21 | 6.836 | -4.18 | 19.05 | 4.219 | -30.651 | -8.124 | -13.259 | 12.597 | -6.151 | 0 | 0 | 0 | 0 |
Inventory
| -7.115 | 1.163 | 4.987 | 0 | 3.822 | 12.105 | -20.025 | -9.065 | -2.529 | 2.708 | 2.116 | -0.995 | -0.244 | 0 | 0 |
Accounts Payables
| -5.464 | -1.163 | -4.987 | -27.638 | 6.441 | -4.302 | 6.232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | -1.163 | -4.987 | 23.099 | -11.842 | -0.083 | -24.419 | -7.531 | -5.373 | 2.392 | -8.613 | -2.551 | -1.267 | 0 | 0 |
Other Non Cash Items
| -4.364 | 0.717 | -0.24 | -1.816 | -36.41 | -49.971 | -53.15 | -0.417 | -1.348 | -1.107 | 1.815 | 0.214 | 0.088 | 0.041 | 1.36 |
Operating Cash Flow
| -33.205 | -16.842 | -15.296 | -29.925 | 73.891 | 53.819 | -17.941 | 30.719 | 16.162 | -3.15 | 9.476 | -9.02 | -30.412 | -25.258 | -34.891 |
Investing Activities: | |||||||||||||||
Investments In Property Plant And Equipment
| -124.116 | -68.072 | -31.309 | -33.494 | -83.641 | -19.677 | -680.656 | -43.883 | -7.272 | -30.5 | -0.63 | -0.535 | -0.159 | -0.023 | -0.445 |
Acquisitions Net
| 0 | 0 | -9.999 | -3.76 | 1,432.816 | 0 | 0 | 0 | -17.225 | -16.658 | -97.067 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | -68.072 | -31.309 | 3.76 | -1,432.816 | 53.795 | -680.401 | -43.529 | -7.23 | -30.299 | 0.001 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| -124.116 | -68.072 | -41.308 | -33.494 | -83.641 | -19.677 | -680.656 | -43.883 | -24.497 | -47.158 | -97.696 | -0.535 | -0.159 | -0.023 | -0.446 |
Financing Activities: | |||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 603.005 | -13.333 | -13.333 | -10 | 39.85 | -0.19 | -0.27 | -0.198 | 0.45 |
Common Stock Issued
| 94.751 | 109.682 | 133.438 | 30.479 | 0.026 | 0.947 | 158.751 | 9.297 | 60 | 36.257 | 31.777 | 85.986 | 0.648 | 38.353 | 20.007 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | -0.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -2.425 | -1.873 | 129.974 | -2.482 | -1,109.18 | -0.089 | -23.804 | -0.175 | -4.063 | -2.208 | -4.037 | -4.95 | -0.124 | 0 | 0 |
Financing Cash Flow
| 92.326 | 107.809 | 129.974 | 27.997 | -0.666 | 0.858 | 737.952 | -4.211 | 42.604 | 24.049 | 67.59 | 80.846 | 0.254 | 38.156 | 20.457 |
Other Information: | |||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 1.764 | -1.667 | 1.393 | 0.268 | 1.056 | -0.026 | 0.001 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -64.995 | 22.895 | 73.37 | -35.422 | -8.652 | 33.333 | 40.748 | -17.107 | 35.325 | -26.285 | -20.629 | 71.291 | -30.317 | 12.875 | -14.88 |
Cash At End Of Period
| 60.555 | 125.55 | 102.655 | 29.285 | 110.785 | 119.437 | 86.104 | 45.356 | 62.463 | 27.138 | 53.423 | 74.052 | 2.761 | 33.078 | 20.203 |